Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideho Okada

Showing results (1-10 of 187) with videos related to

Pageof 19
Sort By:
No Shinkei Geka. Neurological Surgery|May 26, 2005
[Immunotherapy for brain tumor: don't get "Lost in Translation"]Hideho Okada
Yonsei Medical Journal|July 14, 2004
Biologic therapy for brain cancers--based on cellular and immunobiologyHideho Okada
Annals of the New York Academy of Sciences|September 23, 2009
Brain tumor immunotherapy with type-1 polarizing strategiesHideho Okada
Seminars in Immunology|April 23, 2010
Polarized dendritic cells as cancer vaccines: directing effector-type T cells to tumorsPawel Kalinski, Hideho Okada
Journal of Neuro-Oncology|March 19, 2020
T-Cell based therapies for overcoming neuroanatomical and immunosuppressive challenges within the glioma microenvironmentDarwin Kwok, Hideho Okada
Journal for Immunotherapy of Cancer|April 1, 2026
Highlights in IO: next-generation CAR-T therapy for glioblastomaJunya Yamaguchi, Hideho Okada
Current Gene Therapy|December 13, 2002
Gene therapy and biologic therapy with interleukin-4Hideho Okada, Naruo Kuwashima
Expert Opinion on Biological Therapy|July 20, 2016
Cellular immunotherapy for malignant gliomasYi Lin, Hideho Okada
Seminars in Cancer Biology|January 3, 2012
MicroRNAs and STAT interplayGary Kohanbash, Hideho Okada
Immunological Investigations|September 29, 2012
Myeloid-derived suppressor cells (MDSCs) in gliomas and glioma-developmentGary Kohanbash, Hideho Okada
Pageof 19

Showing results (1-10 of 187) with videos related to

Sort By:
Pageof 19
No Shinkei Geka. Neurological Surgery|May 26, 2005
[Immunotherapy for brain tumor: don't get "Lost in Translation"]Hideho Okada
Yonsei Medical Journal|July 14, 2004
Biologic therapy for brain cancers--based on cellular and immunobiologyHideho Okada
Annals of the New York Academy of Sciences|September 23, 2009
Brain tumor immunotherapy with type-1 polarizing strategiesHideho Okada
Seminars in Immunology|April 23, 2010
Polarized dendritic cells as cancer vaccines: directing effector-type T cells to tumorsPawel Kalinski, Hideho Okada
Journal of Neuro-Oncology|March 19, 2020
T-Cell based therapies for overcoming neuroanatomical and immunosuppressive challenges within the glioma microenvironmentDarwin Kwok, Hideho Okada
Journal for Immunotherapy of Cancer|April 1, 2026
Highlights in IO: next-generation CAR-T therapy for glioblastomaJunya Yamaguchi, Hideho Okada
Current Gene Therapy|December 13, 2002
Gene therapy and biologic therapy with interleukin-4Hideho Okada, Naruo Kuwashima
Expert Opinion on Biological Therapy|July 20, 2016
Cellular immunotherapy for malignant gliomasYi Lin, Hideho Okada
Seminars in Cancer Biology|January 3, 2012
MicroRNAs and STAT interplayGary Kohanbash, Hideho Okada
Immunological Investigations|September 29, 2012
Myeloid-derived suppressor cells (MDSCs) in gliomas and glioma-developmentGary Kohanbash, Hideho Okada
Pageof 19